Last week, the U.S. Securities and Exchange Commission reached at $265,000 settlement with BlueLinx Holdings Inc. The SEC alleged that BlueLinx violated federal securities law by using severance agreements that […]
In a recent opinion by Judge Wilkins, the D.C. Circuit affirmed the dismissal of a qui tam action against Phillip Morris, United States ex rel Oliver v. Phillip Morris USA, […]
Last week, Judge McMahon (S.D.N.Y.) denied a motion to dismiss in a notable False Claims Act case against Teva Pharmaceuticals. Although the court allowed the case to proceed, it rejected […]
Pressure continues to build for the Department of Justice to hold corporate executives criminally responsible for corporate misconduct. As previously discussed here and here, Deputy Attorney General Sally Yates recently […]
Posted by Jonathan Cohn, Paul Ray and Ben Mundel A recent decision by a federal district court highlights some of the dangers of qui tam suits under the False Claims Act brought […]
Posted by Jonathan Cohn and Benjamin Mundel On Monday, the United States Supreme Court granted certiorari in Lawson v. FMR LLC, No. 12-3 (certiorari granted May 20, 2013). The issue presented […]